This MAPS podcast details potential areas for compliant collaboration by MSLs with Academic Drug Developers.
At some point, many people feel they’re simply “not good enough.” Unfortunately, this is such a common occurrence that it has a name: Imposter Syndrome.
“Data doesn’t exist until it is published.” Here, MAPS speaks with MedComm FAWG co-leads about innovations and future directions for Medical Communications within Medical Affairs.
This MAPS podcast details potential areas for compliant collaboration by MSLs with Patient Advocacy Groups.
A Q&A with David Williams, Chief Medical Officer, VISFO
Since its publication in the journal of Therapeutic Innovation & Regulatory Science in July, the article “Promoting Best Practices for Medical Science Liaisons Position Statement from the APPA, IFAPP, MAPS and MSLS,” has been read more than 4000 times. This article presents highlights from a recent MAPS webinar with the paper’s authors, focusing on further defining the role and best practices for Medical Science Liaisons.
When quantitative and qualitative Field Medical KPIs and metrics are aligned with the organization’s strategic plan, these measurements demonstrate value. Defining and communicating this value is an essential task as Field Medical solidifies its role as a strategic pillar within the organization.
This paper discusses the sources and uses of non-registrational evidence and describes why Medical Affairs is positioned to lead and own the nRE Strategic Plan.
Near the end of Jill Donahue’s family trip to Greece, an unlicensed tour guide, Charis, showed what communication mastery looks like.
This MAPS podcast details potential areas for compliant collaboration by MSLs with key external partners.